Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial
Paul G. Richardson(Harvard University), Robert J. Soiffer(Dana-Farber Cancer Institute), Joel A. Brochstein(Cohen Children's Medical Center), Alfred P. Gillio(University Medical Center), Eneida R. Nemecek(Oregon Health & Science University), Sally Arai(Stanford Medicine), Joseph H. Antin(Dana-Farber Cancer Institute), Eva C. Guinan(Dana-Farber Cancer Institute), Shin Mineishi(University of Alabama at Birmingham), Massimo Iacobelli(Figli Adottivi e Genitori Naturali), Gideon Steinbach(University of Washington), Stephan A. Grupp(Children's Hospital of Philadelphia), Nancy A. Kernan(Memorial Sloan Kettering Cancer Center), Paul Martin(Duke Medical Center), Maja Miloslavsky(Janssen (United States)), Bijan Nejadnik(Janssen (United States)), Alison L. Hannah(CytomX Therapeutics (United States)), Reggie Duerst(Lurie Children's Hospital), Robin Hume(Jazz Pharmaceuticals (United States)), Rajinder Bajwa(Nationwide Children's Hospital), Amrita Krishnan(City of Hope), Leslie Lehmann(Harvard University)
Cited by 1
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k